Skip to main content
SpringerLink
Log in

Assessing the responsiveness of the Asthma Quality of Life Questionnaire with pharmaceutical care

  • Research Article
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Objective To assess the responsiveness of the Asthma Quality of Life Questionnaire (AQLQ) in the context of pharmaceutical care delivery New Zealand community pharmacy setting. Setting Community pharmacy practices in three locations in the Otago and Southland region of New Zealand. Method About 62 patients with asthma (17–80 years of age) were recruited in five community pharmacies in the Otago and the Southland region of New Zealand. Patients were randomly assigned to two groups (Group 1 and Group 2). The AQLQ and a study-specific outcomes questionnaire were administered to both groups at baseline (T1), then again (with an additional global Self-Assessment of change question) 3 months later (at T2) after providing the service to Group 1. Responsiveness of the AQLQ was assessed by measuring the ability of the AQLQ to detect within-subject change in patients who subjectively indicated change, and to distinguish between two groups of patients: those who indicated change and those who indicated no change. Additionally, the correlation between the change of the AQLQ scores at T2 and the patients’ self-assessment of change at T2 was estimated and used as means for assessing the AQLQ responsiveness. Main outcome measure Asthma-specific quality of life as measured by the AQLQ and change in quality of life as perceived by participants. Results The results supported the responsiveness of three out of the four domains of the Asthma Quality of Life Questionnaire. The fourth domain, Environmental stimuli, showed weaker responsiveness, and the reasons of this were discussed. Conclusion This study provided data supporting the responsiveness of the AQLQ when used in the context of pharmaceutical care. However, while the AQLQ’s Activity Limitation, Symptoms and Emotional domains reflected adequate sensitivity to change in QoL over time, its Environmental domain was less sensitive. Researchers conducting longitudinal studies utilising the AQLQ in pharmaceutical care interventions should bear this in mind, and should consider the possible reasons for this apparent lack of responsiveness, and its implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures—statistics and strategies for evaluation. Control Clin Trials 1991;1(4 Suppl):142S–58S.

    Article  Google Scholar 

  2. Ware JE, Gandek BL, Keller SD. Evaluating instruments used cross-nationally: methods from the IQOLA project. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1996. ISBN-13: 978-0781703321.

  3. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47(3):533–43.

    PubMed  CAS  Google Scholar 

  4. Kheir N, van Mil JWF, Shaw J, Sheridan J. Health related quality of life measurement in pharmaceutical care: targeting an outcome that matters. Pharm World Sci 2004;26(3):125–28.

    Article  PubMed  Google Scholar 

  5. Kirshner B, Guyatt GH. A methodological framework for assessing health indices. J Chronic Dis 1985;38(1):27–36.

    Article  PubMed  CAS  Google Scholar 

  6. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993;147(4):832–8.

    PubMed  CAS  Google Scholar 

  7. Ware JE, Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res 1998;7:235–44.

    Article  PubMed  Google Scholar 

  8. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999;115(5):1265–70.

    Article  PubMed  CAS  Google Scholar 

  9. Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993;148(3):675–81.

    PubMed  CAS  Google Scholar 

  10. Strand LM, Cipolle RJ, Morley PC, et al. Levels of pharmaceutical care: a needs-based approach. Am J Hosp Pharm 1991;48:547–50.

    PubMed  CAS  Google Scholar 

  11. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171–8.

    Article  PubMed  CAS  Google Scholar 

  12. Rutten-van Molken MP, Custers F, van Doorslaer EK, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995;8(6):888–98.

    PubMed  CAS  Google Scholar 

  13. Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993;148(3):675–81.

    PubMed  CAS  Google Scholar 

  14. Ware JE, Konsiniski M, Keller SD. SF-36 physical and mental health summary scales: a user’s manual. Boston (MA): The Health Institute; 1994.

    Google Scholar 

  15. Raphael D. Defining quality of life. In: Renwick R, Brown I, Nagler M, editors. Quality of life in health promotion and rehabilitation. New York: Sage Publications Inc.; 1996.

  16. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27(3 Suppl):S178–89.

    Article  PubMed  CAS  Google Scholar 

  17. Scientific Advisory Committee. Instrument Review Criteria. Medical Outcomes Trust Bulletin, September 1995.

Download references

Funding

This work has been funded by the New Zealand Health Funding Authority and Glaxo-Wellcome-NZ Ltd.

Conflics of interest

None

Author information

Authors and Affiliations

  1. Pharmacy Program, Qatar University, P.O. Box 2713, Doha, Qatar

    Nadir M. Kheir

  2. School of Pharmacy, University of Queensland, Brisbane, 4072, Australia

    Lynne Emmerton

  3. School of Pharmacy, The University of Auckland, Private Bag 92019, Auckland, New Zealand

    John P. Shaw

Authors
  1. Nadir M. Kheir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lynne Emmerton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John P. Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nadir M. Kheir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kheir, N.M., Emmerton, L. & Shaw, J.P. Assessing the responsiveness of the Asthma Quality of Life Questionnaire with pharmaceutical care. Pharm World Sci 30, 322–328 (2008). https://doi.org/10.1007/s11096-007-9179-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-007-9179-y

Keywords

Search

Navigation